Ellis Ilene, Schnabel Lauren V, Berglund Alix K
Department of Clinical Sciences, College of Veterinary Medicine, North Carolina State University, Raleigh, NC, USA.
Comparative Medicine Institute, North Carolina State University, Raleigh, NC, USA.
J Immunol Regen Med. 2022 May;16. doi: 10.1016/j.regen.2022.100059. Epub 2022 Mar 4.
Cytokine manipulation has been widely used to bolster innate healing mechanisms in an array of modern therapeutics. While other anatomical locations have a more definitive analysis of cytokine data, the tendon presents unique challenges to detection that make a complete portrayal of cytokine involvement during injury unattainable thus far. Without this knowledge, the advancement of tendon healing modalities is limited. In this review, we discuss what is known of the cytokine profile within the injured tendinous environment and the unique obstacles facing cytokine detection in the tendon while proposing possible solutions to these challenges. IL-1β, TNF-α, and IL-6 in particular have been identified as key cytokines for initiating tendon healing, but their function and temporal expression are still not well understood. Methods used for cytokine evaluation in the tendon including cell culture, tissue biopsy, and microdialysis have their strengths and limitations, but new methods and approaches are needed to further this research. We conclude that future study design for cytokine detection in the injured tendon should meet set criteria to achieve definitive characterization of cytokine expression to guide future therapeutics.
细胞因子调控已广泛应用于一系列现代治疗手段中,以增强机体的固有愈合机制。尽管其他解剖部位对细胞因子数据已有更确切的分析,但肌腱在细胞因子检测方面存在独特挑战,这使得迄今为止尚无法完整描绘损伤过程中细胞因子的参与情况。缺乏这方面的知识,肌腱愈合方式的进展就会受到限制。在本综述中,我们讨论了损伤肌腱环境中的细胞因子概况,以及肌腱细胞因子检测所面临的独特障碍,同时提出了应对这些挑战的可能解决方案。特别是白细胞介素-1β(IL-1β)、肿瘤坏死因子-α(TNF-α)和白细胞介素-6(IL-6)已被确定为启动肌腱愈合的关键细胞因子,但其功能和时间表达仍未完全明确。用于肌腱细胞因子评估的方法,包括细胞培养、组织活检和微透析,各有优缺点,但仍需要新的方法和途径来推进这项研究。我们得出结论,未来损伤肌腱细胞因子检测的研究设计应符合既定标准,以实现细胞因子表达的确切表征,从而指导未来的治疗。